1. Home
  2. GPCR vs CMRE Comparison

GPCR vs CMRE Comparison

Compare GPCR & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • CMRE
  • Stock Information
  • Founded
  • GPCR 2016
  • CMRE 1974
  • Country
  • GPCR United States
  • CMRE Monaco
  • Employees
  • GPCR N/A
  • CMRE N/A
  • Industry
  • GPCR
  • CMRE Marine Transportation
  • Sector
  • GPCR
  • CMRE Consumer Discretionary
  • Exchange
  • GPCR Nasdaq
  • CMRE Nasdaq
  • Market Cap
  • GPCR 1.1B
  • CMRE 1.0B
  • IPO Year
  • GPCR 2023
  • CMRE 2010
  • Fundamental
  • Price
  • GPCR $19.01
  • CMRE $9.50
  • Analyst Decision
  • GPCR Strong Buy
  • CMRE Hold
  • Analyst Count
  • GPCR 7
  • CMRE 2
  • Target Price
  • GPCR $76.17
  • CMRE $13.50
  • AVG Volume (30 Days)
  • GPCR 684.5K
  • CMRE 535.1K
  • Earning Date
  • GPCR 08-07-2025
  • CMRE 07-30-2025
  • Dividend Yield
  • GPCR N/A
  • CMRE 4.89%
  • EPS Growth
  • GPCR N/A
  • CMRE N/A
  • EPS
  • GPCR N/A
  • CMRE 2.44
  • Revenue
  • GPCR N/A
  • CMRE $2,054,690,000.00
  • Revenue This Year
  • GPCR N/A
  • CMRE N/A
  • Revenue Next Year
  • GPCR N/A
  • CMRE N/A
  • P/E Ratio
  • GPCR N/A
  • CMRE $3.89
  • Revenue Growth
  • GPCR N/A
  • CMRE 18.22
  • 52 Week Low
  • GPCR $13.22
  • CMRE $6.63
  • 52 Week High
  • GPCR $47.48
  • CMRE $15.96
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 33.96
  • CMRE 58.02
  • Support Level
  • GPCR $18.50
  • CMRE $9.00
  • Resistance Level
  • GPCR $19.40
  • CMRE $9.53
  • Average True Range (ATR)
  • GPCR 1.18
  • CMRE 0.27
  • MACD
  • GPCR -0.17
  • CMRE 0.01
  • Stochastic Oscillator
  • GPCR 9.86
  • CMRE 82.89

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

Share on Social Networks: